770 related articles for article (PubMed ID: 16982942)
1. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B
Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942
[TBL] [Abstract][Full Text] [Related]
2. Letter by Xia regarding article, "High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor".
Xia P
Circulation; 2007 Apr; 115(14):e393; author reply e394. PubMed ID: 17420358
[No Abstract] [Full Text] [Related]
3. High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors.
Kimura T; Sato K; Malchinkhuu E; Tomura H; Tamama K; Kuwabara A; Murakami M; Okajima F
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1283-8. PubMed ID: 12775579
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.
Walter DH; Rochwalsky U; Reinhold J; Seeger F; Aicher A; Urbich C; Spyridopoulos I; Chun J; Brinkmann V; Keul P; Levkau B; Zeiher AM; Dimmeler S; Haendeler J
Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):275-82. PubMed ID: 17158356
[TBL] [Abstract][Full Text] [Related]
5. Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury.
Herzog C; Schmitz M; Levkau B; Herrgott I; Mersmann J; Larmann J; Johanning K; Winterhalter M; Chun J; Müller FU; Echtermeyer F; Hildebrand R; Theilmeier G
Mediators Inflamm; 2010; 2010():425191. PubMed ID: 21274265
[TBL] [Abstract][Full Text] [Related]
6. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate.
Frias MA; James RW; Gerber-Wicht C; Lang U
Cardiovasc Res; 2009 May; 82(2):313-23. PubMed ID: 19151362
[TBL] [Abstract][Full Text] [Related]
7. [Measurement of sphingosine 1-phosphate as a biomarker of atherosclerosis].
Kimura T; Okajima F; Murakami M
Rinsho Byori; 2007 Apr; 55(4):358-62. PubMed ID: 17511266
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43.
Morel S; Christoffersen C; Axelsen LN; Montecucco F; Rochemont V; Frias MA; Mach F; James RW; Naus CC; Chanson M; Lampe PD; Nielsen MS; Nielsen LB; Kwak BR
Cardiovasc Res; 2016 Mar; 109(3):385-96. PubMed ID: 26762268
[TBL] [Abstract][Full Text] [Related]
9. Targeting sphingosine-1-phosphate signalling for cardioprotection.
Kennedy S; Kane KA; Pyne NJ; Pyne S
Curr Opin Pharmacol; 2009 Apr; 9(2):194-201. PubMed ID: 19070545
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury.
Means CK; Xiao CY; Li Z; Zhang T; Omens JH; Ishii I; Chun J; Brown JH
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2944-51. PubMed ID: 17293497
[TBL] [Abstract][Full Text] [Related]
11. High-density lipoprotein stimulates myocardial perfusion in vivo.
Levkau B; Hermann S; Theilmeier G; van der Giet M; Chun J; Schober O; Schäfers M
Circulation; 2004 Nov; 110(21):3355-9. PubMed ID: 15545521
[TBL] [Abstract][Full Text] [Related]
12. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin.
González-Díez M; Rodríguez C; Badimon L; Martínez-González J
Thromb Haemost; 2008 Jul; 100(1):119-26. PubMed ID: 18612546
[TBL] [Abstract][Full Text] [Related]
13. The natural cardioprotective particle HDL modulates connexin43 gap junction channels.
Morel S; Frias MA; Rosker C; James RW; Rohr S; Kwak BR
Cardiovasc Res; 2012 Jan; 93(1):41-9. PubMed ID: 21960685
[TBL] [Abstract][Full Text] [Related]
14. Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury.
Brulhart-Meynet MC; Braunersreuther V; Brinck J; Montecucco F; Prost JC; Thomas A; Galan K; Pelli G; Pedretti S; Vuilleumier N; Mach F; Lecour S; James RW; Frias MA
PLoS One; 2015; 10(3):e0119664. PubMed ID: 25781943
[TBL] [Abstract][Full Text] [Related]
15. Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways.
Kim M; Kim M; Kim N; D'Agati VD; Emala CW; Lee HT
Am J Physiol Renal Physiol; 2007 Dec; 293(6):F1827-35. PubMed ID: 17898040
[TBL] [Abstract][Full Text] [Related]
16. Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction.
Knapp M; Baranowski M; Czarnowski D; Lisowska A; Zabielski P; Górski J; Musiał W
Med Sci Monit; 2009 Sep; 15(9):CR490-3. PubMed ID: 19721401
[TBL] [Abstract][Full Text] [Related]
17. Deletion of the sphingosine kinase-1 gene influences cell fate during hypoxia and glucose deprivation in adult mouse cardiomyocytes.
Tao R; Zhang J; Vessey DA; Honbo N; Karliner JS
Cardiovasc Res; 2007 Apr; 74(1):56-63. PubMed ID: 17320845
[TBL] [Abstract][Full Text] [Related]
18. Synthetic high-density lipoproteins exert cardioprotective effects in myocardial ischemia/reperfusion injury.
Rossoni G; Gomaraschi M; Berti F; Sirtori CR; Franceschini G; Calabresi L
J Pharmacol Exp Ther; 2004 Jan; 308(1):79-84. PubMed ID: 14566009
[TBL] [Abstract][Full Text] [Related]
19. Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection.
Somers SJ; Frias M; Lacerda L; Opie LH; Lecour S
Cardiovasc Drugs Ther; 2012 Jun; 26(3):227-37. PubMed ID: 22392184
[TBL] [Abstract][Full Text] [Related]
20. Proximal cerebral arteries develop myogenic responsiveness in heart failure via tumor necrosis factor-α-dependent activation of sphingosine-1-phosphate signaling.
Yang J; Noyan-Ashraf MH; Meissner A; Voigtlaender-Bolz J; Kroetsch JT; Foltz W; Jaffray D; Kapoor A; Momen A; Heximer SP; Zhang H; van Eede M; Henkelman RM; Matthews SG; Lidington D; Husain M; Bolz SS
Circulation; 2012 Jul; 126(2):196-206. PubMed ID: 22668972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
